7 terminated. 7 Phase 2, 1 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 7 | Terminated 7 |
| Phase 1 | 1 | Terminated 1 |
| Phase 3 | 1 | Terminated 1 |
Follow Puerperal Disorders: new trials by email Literature Review of Puerperal Disorders trials Research Report on Puerperal Disorders
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase 2 Clinical Trial of GH001 in Postpartum Depression GH001 - Postpartum Depression, Postnatal Depression | Phase 2 | Terminated | GH Research Ireland Limited | 10 | 2023-03-02 | 2025-02-18 |
| Efficacy And Tolerability Of Sub-Anesthetic Ketamine In Postpartum Depression Ketamine 0.5 mg/kg, Ketamine 0.2 mg/kg - Post Partum Depression | Phase 2 | Terminated | The University of Texas Health Science Center, Houston | 1 | 2019-03-04 | 2021-10-19 |
| Tampostat for Management of Postpartum Hemorrhage Tampostat, Condom catheter tamponade - Postpartum Hemorrhage | Phase 1 / Phase 2 | Terminated | International Centre for Diarrhoeal Disease Research, Bangladesh | 344 | 2015-04-01 | 2018-11-26 |
| Tranexamic Acid and Thromboelastography During Cesarean Delivery Tranexamic Acid, Placebo; Normal Saline - Postpartum Hemorrhage | Phase 2 | Terminated | Brigham and Women's Hospital | 60 | 2014-07-01 | 2020-10-27 |
| Controlled Randomised Trial of Ferric Carboxymaltose and Oral Iron to Treat Postpartum Anemia Ferric carboxymaltose, Ferrous sulfate tablets - Anemia, Iron-Deficiency, Puerperal Disorders | Phase 2 / Phase 3 | Terminated | Norwegian University of Science and Technology | 30 | 2009-06-01 | 2012-02-17 |
| Quetiapine in Postpartum Depression Quetiapine - Postpartum Depressive Disorder | Phase 2 | Terminated | AstraZeneca | 5 | 2007-08-01 | 2010-12-21 |
| Clinical Trial of Estrogen for Postpartum Depression 17beta Estradiol, Placebos - Postpartum Depression, Depression | Phase 2 | Terminated | National Institute of Mental Health (NIMH) | 12 | 2003-04-17 | 2018-06-13 |
Depression, Postpartum (5) · Depression (2) · Postpartum Hemorrhage (2) · Anemia, Iron-Deficiency (1) · Thrombosis (1)
Female Urogenital Diseases and Pregnancy Complications (7) · Pregnancy Complications (7) · Urogenital Diseases (7) · Depressive Disorder (5) · Mental Disorders (5) · Mood Disorders (5) · Behavior (2) · Behavioral Symptoms (2) · Hemorrhage (2) · Obstetric Labor Complications (2) · Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2) · Uterine Hemorrhage (2) · Anemia (1)
Estradiol (1) · Iron-Dextran Complex (1) · Ketamine (1) · Methoxydimethyltryptamines (1) · Quetiapine Fumarate (1) · Saline Solution (1) · Tranexamic Acid (1) · ferric carboxymaltose (1)
AstraZeneca (1) · Brigham and Women's Hospital (1) · GH Research Ireland Limited (1) · International Centre for Diarrhoeal Disease Research, Bangladesh (1) · National Institute of Mental Health (NIMH) (1) · Norwegian University of Science and Technology (1) · The University of Texas Health Science Center, Houston (1)
United States (3) · Bangladesh (1) · Germany (1) · Netherlands (1) · Norway (1) · United Kingdom (1)
Aminur Rahman, MBBS,MSc (1) · Bjorn Backe, MD PhD (1) · Luc Turmes, MD (1) · Peter J Schmidt, M.D. (1) · Sudhakar Selvaraj, 713-486-2837 (1)
PMID 10467792, PMID 10908457, PMID 11502292, PMID 14600674, PMID 15954876, PMID 16581405, PMID 16842791, PMID 17197859, PMID 17634155, PMID 19432563, PMID 19943825, PMID 20009308, PMID 22540529, PMID 22882240, PMID 32609374, PMID 42247279
2008 (1)